Skip to main content

Table 4 Patient characteristics in the thoracic surgery and non-thoracic surgery groups

From: Clinical impact of prevalence and severity of COPD on the decision-making process for therapeutic management of lung cancer patients

 

All cases (n = 185)

Non-surgery (n = 50)

Surgery (n = 135)

p value

Cases

100 (185)

27.0 (50)

73.0 (135)

0.0001 #

Age, years a

70.3 (39–88)

74.6 (62–80)

68.7 (39–86)

0.0001 #

Sex, male

72.4 (134)

76.0 (38)

71.1 (96)

0.581

History of smoking

78.9 (213)

82.0 (41)

77.0 (104)

0.549

COPD diagnosed b

49.7 (92)

66.0 (33)

43.7 (59)

0.012 #

COPD managed c

9.2 (17)

20.0 (10)

5.2 (7)

0.004 #

COPD-related systemic comorbidities

57.3 (106)

60.0 (30)

56.3 (76)

0.739

Diabetes

20.0 (37)

30.0 (15)

16.3 (22)

0.061

Ischemic disease

7.6 (14)

10.0 (5)

6.7 (9)

0.532

Hypertension

40.5 (75)

40.0 (20)

40.7 (55)

1.000

Hyperlipidemia

11.4 (21)

10.0 (5)

11.8 (16)

0.799

  1. n indicates number.
  2. aData are shown as mean (range).
  3. bindicates the patients who were firstly diagnosed as COPD at bronchoscopy.
  4. cindicates the patients who had been diagnosed as COPD before bronchoscopy.
  5. All other data are shown as% (numbers).
  6. #p < 0.05.
  7. COPD: chronic obstructive pulmonary disease.